A Phase 2 interventional study of Vitamin C 500 MG Oral Capsule and placebo in Diabetes Mellitus Type 2 With Hyperglycemia and Periodontitis, sponsored by Mahidol University. Status unknown at 1 site in Thailand. Per ClinicalTrials.gov, last updated 2017-09-01.
Sponsored by Mahidol University · Phase 2, Interventional, and Treatment
Periodontitis patients with uncontrolled type 2 diabetes mellitus will receive non-surgical periodontal treatment and then be supplemented with daily 500 mg vitamin C (test group) or placebo (control group) for 2 months. Clinical parameters will be retrieved at baseline, at the end of week 4 and at the end of week 8.
1,232 studies on the registry are indexed under Periodontitis; 295 are open to participants now.
This study's planned enrollment of 30 is below the median of 44 across 846 interventional studies indexed under Periodontitis.
Browse Periodontitis studies →Mahidol University is the lead sponsor of 747 studies on the registry; 119 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
HIV
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
vitamin C 500 mg oral capsule
Drug: Vitamin C 500 MG Oral Capsule
placebo
Other: placebo
non surgical periodontal treatment+vitamin C 500 mg/day for 2 months
non surgical periodontal treatment+placebo for 2 months
sulcus bleeding index
bleeding upon probing of gingival sulcus from the most severe periodontitis tooth
Time frame: baseline, change from baseline sulcus bleeding index at 4 weeks, change from baseline sulcus bleeding index at 8 weeks
Plan to share: Undecided
No publications or documents are linked to this record.
Start is estimated for Aug 2017; primary completion for Feb 2018, 5 months later.
Of 18 phase 2 interventional studies under Periodontitis, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 21. This study's planned 5 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Ascorbic Acid